PSMA (Prostate-Specific Membrane Antigen) is a radioactive imaging agent that is used to investigate primary and metastatic prostate cancer with a specialised imaging scan called a Positron Emission Tomography (PET) scan. This product has been used in patients with prostate cancer to assess response to treatment and to investigate recurrence of disease. By injecting a small amount of radioactive PSMA into a vein, we can use our combined PET-CT scanner to diagnose, locate and assess this condition.
Your total time at our Centre for Nuclear Medicine and PET-CT will be approximately 2 hours but the scan itself will only be about 15-20 minutes. Please arrive 20 minutes prior to your booked time.
Find your imaging service